Zhejiang Medicine
Zhejiang Medicine is a Shanghai-listed Chinese pharmaceutical and nutritional-ingredients manufacturer producing vitamins — principally beta carotene and biotin — for pharmaceutical, nutraceutical, food, and animal feed customers globally.
- Company typePrivate
- Founded1997
- HeadquartersShaoxing, China
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Zhejiang Medicine does
Zhejiang Medicine (sse:600216) is a Shanghai-listed Chinese pharmaceutical and nutritional-ingredients manufacturer founded in 1997 and headquartered in Shaoxing, with a workforce in the 5,001–10,000 range. The company produces vitamins and carotenoid ingredients — principally beta carotene and biotin — for sale into pharmaceutical, nutraceutical, food, and animal feed end-markets. It is identified by third-party industry analyses as one of the key global market participants in beta carotene (alongside BASF SE, DSM-Firmenich, Divi's Neutraceuticals, and Adama/LycoRed) and in biotin (alongside DSM-Firmenich, BASF SE, and Xiamen Kingdomway Group).
The company operates as a B2B ingredient supplier with a horizontal segmentation strategy, spanning human nutrition (addressing micronutrient deficiencies and dietary supplement needs) and animal feed (addressing nutritional requirements in animal husbandry). Its product portfolio centers on two flagships: beta carotene, a carotenoid pigment used as a colorant and nutritional supplement in food, beverage, supplement, and pharmaceutical applications; and biotin, a B-vitamin supplement used across dietary supplements and animal feed. The source material indicates active expansion of production capacity and R&D capabilities for biotin, with no disclosed pricing model, marketing channel detail, or customer-logo-level disclosure.
Revenue mechanics are not transparently disclosed in the input. The company appears to generate revenue through direct B2B sales of bulk nutritional ingredients to downstream manufacturers across its two principal segments, but no ARR, pricing, or contract-structure detail is available. The company website (china-zmc.com) currently serves a default nginx page, indicating limited first-party digital presence at the time of data collection. Information on ownership structure, management team, M&A activity, partnerships, and certifications is not disclosed in the provided source material, and the financial figures supplied appear to carry unit/labeling inconsistencies that prevent direct triangulation of revenue magnitude.
Zhejiang Medicine firmographics
Firmographics- Name
- Zhejiang Medicine
- Legal name
- Zhejiang Medicine
- Website
- https://china-zmc.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Zhejiang Medicine is a Shanghai-listed Chinese pharmaceutical and nutritional-ingredients manufacturer producing vitamins — principally beta carotene and biotin — for pharmaceutical, nutraceutical, food, and animal feed customers globally.
- Ownership category
- akta.pro rank
Zhejiang Medicine industry classification
Industry- Product category
- Nutritional Ingredients Manufacturing
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)
- akta.pro secondary industry
- Vitamins, Minerals & Multivitamin Supplements (HLAMALAF)
Keywords
Where Zhejiang Medicine is headquartered
LocationHeadquarters
- HQ city
- Shaoxing
- HQ country
- China
- HQ region
- Asia
Markets served
Zhejiang Medicine business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D
Zhejiang Medicine product offering
Product offeringCore offering
Zhejiang Medicine is a Chinese pharmaceutical and nutritional ingredient manufacturer that produces vitamins and nutraceutical products, principally beta carotene and biotin. Its products serve human nutrition (dietary supplements, food, beverage, and pharmaceutical applications) and animal feed applications. The company is identified as a key market participant in the global beta carotene and biotin markets and is expanding its production and R&D capabilities.
Product overview
Zhejiang Medicine is a Chinese pharmaceutical and nutritional ingredient manufacturer that produces vitamins and nutritional supplements for human nutrition and animal feed applications. The company is identified as a key market participant in the beta carotene market and is expanding its production and R&D capabilities for biotin products. The product portfolio centers on nutritional ingredients including beta carotene and biotin, serving both human nutrition and animal feed sectors.
Differentiator
Problem solved
Functional benefit
Products and services
- Beta Carotene
- Biotin
Companies that use Zhejiang Medicine
Customer profileSegments2 records
Ideal customer profiles2 records
Zhejiang Medicine technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Zhejiang Medicine partnerships and signals
Strategic signalScale indicators2 records
Recent moves3 records
Expansion highlights3 records
Zhejiang Medicine competitors and assessment
Company assessmentEmerging players
- Glanbia Nutritionals: Glanbia Nutritionals is a global nutrition solutions provider offering premixes, vitamins, and functional ingredients to supplement and food brands. Comparable as a supplier serving nutraceutical and food customers, but with a differentiated premix/formulation focus rather than primary vitamin API manufacturing.
Direct peers
- Zhejiang NHU Company: Zhejiang NHU is a major Chinese vitamins and API manufacturer with overlapping product lines (notably vitamin A, E, and other nutritional ingredients) and similar B2B nutrition/pharma customer base. Highly comparable as a domestic Chinese peer in ingredient manufacturing.
- DSM-Firmenich: DSM-Firmenich is one of the world's largest vitamins and nutraceutical ingredients producers and is co-listed with Zhejiang Medicine as a key player in both the beta carotene and biotin markets, making it the most directly comparable peer for product overlap and customer base.
- Divi's Laboratories: Divi's Laboratories (with its Divi's Nutraceuticals arm) is cited as a key participant in the global beta carotene market alongside Zhejiang Medicine. Comparable as an active ingredient/nutraceutical manufacturer serving global supplement and nutrition buyers.
- Northeast Pharmaceutical Group: Northeast Pharmaceutical Group (NEPG) is one of China's largest API and vitamin producers. Comparable as a domestic Chinese peer producing vitamin ingredients for pharma, nutraceutical, and feed applications, although broader in scope than Zhejiang Medicine.
- Xiamen Kingdomway Group Company: Xiamen Kingdomway is a Chinese manufacturer competing directly with Zhejiang Medicine in the global biotin market and overlapping in vitamin and nutritional ingredient production, making it a closely matched Chinese competitor.
- Adama (LycoRed): Adama's LycoRed business is identified alongside Zhejiang Medicine as a key beta carotene market participant. Comparable as a producer of natural carotenoid ingredients serving nutraceutical, food, and feed customers.
- BASF SE: BASF SE is identified alongside Zhejiang Medicine as a key participant in both the beta carotene and biotin global markets, with a broader nutrition and health ingredients portfolio. BASF is comparable as a direct competitor in commodity vitamin production serving nutrition, feed, and pharma channels.
Broad incumbents
- Lonza Group: Lonza is a global CDMO and API/ingredient manufacturer with significant nutritional ingredients exposure. Comparable as a broader incumbent offering manufacturing services and APIs that include vitamin and nutraceutical-related production for B2B buyers.
- CSPC Pharmaceutical Group: CSPC is a major Chinese pharmaceutical company with a diversified portfolio spanning APIs, finished drugs, and some nutritional/health ingredients. Comparable as a broader Chinese incumbent in pharmaceutical manufacturing with partial overlap in nutritional ingredients.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Zhejiang Medicine social profiles
Digital presenceZhejiang Medicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zhejiang Medicine leadership team
Management profileNumber of profiles
Zhejiang Medicine funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zhejiang Medicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zhejiang Medicine
What does Zhejiang Medicine do?
Zhejiang Medicine is a Chinese pharmaceutical and nutritional ingredient manufacturer that produces vitamins and nutraceutical products, principally beta carotene and biotin. Its products serve human nutrition (dietary supplements, food, beverage, and pharmaceutical applications) and animal feed applications. The company is identified as a key market participant in the global beta carotene and biotin markets and is expanding its production and R&D capabilities.
When was Zhejiang Medicine founded?
Zhejiang Medicine was founded in 1997. It employs 5,001 to 10,000 people.
Where is Zhejiang Medicine based?
Zhejiang Medicine is headquartered in Shaoxing, China, in the Asia region.
Who are Zhejiang Medicine's main competitors?
Glanbia Nutritionals is listed as an emerging player. Direct peers are Zhejiang NHU Company, DSM-Firmenich, Divi's Laboratories, Northeast Pharmaceutical Group, Xiamen Kingdomway Group Company, Adama (LycoRed) and BASF SE. Broad incumbents are Lonza Group and CSPC Pharmaceutical Group.
Does Zhejiang Medicine have an API?
No public API is recorded for Zhejiang Medicine.
What industry is Zhejiang Medicine in?
Zhejiang Medicine's product category is Nutritional Ingredients Manufacturing. Its primary akta.pro industry code is EUAAAIAK, Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives, with a secondary code of HLAMALAF, Vitamins, Minerals & Multivitamin Supplements. Its NAICS code is 325411 and its SIC code is 2833.